Patents by Inventor Erika Bartolini

Erika Bartolini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMV vaccines
    Patent number: 9987345
    Abstract: The invention is in the field of outer membrane vesicles (OMV) and their uses. More particularly the present invention provides OMV obtained from a bacterium being an ompA mutant and/or a mutant in one or more components of the TolPal complex and presenting a heterologous antigen on its surface. The heterologous antigen is selected from the group consisting of Chlamydia trachomatis CT823, CT681, CT372, CT443, CT043, CT733, CT279, CT601 and CT153 for the treatment, prevention or diagnosis of Chlamydia infection.
    Type: Grant
    Filed: July 21, 2015
    Date of Patent: June 5, 2018
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Renata Maria Grifantini, Oretta Finco, Erika Bartolini, Guido Grandi
  • OMV VACCINES
    Publication number: 20160067327
    Abstract: The invention is in the field of outer membrane vesicles (OMV) and their uses. More particularly the present invention provides OMV obtained from a bacterium being an ompA mutant and/or a mutant in one or more components of the TolPal complex and presenting a heterologous antigen on its surface. The heterologous antigen is selected from the group consisting of Chlamydia trachomatis CT823, CT681, CT372, CT443, CT043, CT733, CT279, CT601 and CT153 for the treatment, prevention or diagnosis of Chlamydia infection.
    Type: Application
    Filed: July 21, 2015
    Publication date: March 10, 2016
    Inventors: Renata Maria Grifantini, Oretta Finco, Erika Bartolini, Guido Grandi
  • OMV vaccines
    Patent number: 9125864
    Abstract: The invention is in the field of outer membrane vesicles (OMV) and their uses. More particularly the present invention provides OMV obtained from a bacterium being an ompA mutant and/or a mutant in one or more components of the TolPal complex and presenting a heterologous antigen on its surface. The heterologous antigen is selected from the group consisting of Chlamydia trachomatis CT823, CT681, CT372, CT443, CT043, CT733, CT279, CT601 and CT153 for the treatment, prevention or diagnosis of Chlamydia infection.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: September 8, 2015
    Assignee: Novartis AG
    Inventors: Renata Maria Grifantini, Erika Bartolini, Oretta Finco, Guido Grandi
  • OMV VACCINES
    Publication number: 20130195907
    Abstract: The invention is in the field of outer membrane vesicles (OMV) and their uses. More particularly the present invention provides OMV obtained from a bacterium being an ompA mutant and/or a mutant in one or more components of the TolPal complex and presenting a heterologous antigen on its surface. The heterologous antigen is selected from the group consisting of Chlamydia trachomatis CT823, CT681, CT372, CT443, CT043, CT733, CT279, CT601 and CT153 for the treatment, prevention or diagnosis of Chlamydia infection.
    Type: Application
    Filed: June 10, 2011
    Publication date: August 1, 2013
    Applicant: Norvartis AG
    Inventors: Renata Maria Grifantini, Erika Bartolini, Oretta Finco, Guido Grandi
  • DIAGNOSTIC AND THERAPEUTIC METHODS FOR RHEUMATIC HEART DISEASE BASED UPON GROUP A STREPTOCOCCUS MARKERS
    Publication number: 20120276130
    Abstract: This invention is in the field of identifying patients having rheumatic heart disease (RHD) associated with Streptococcus pyogenes (Group A Streptococcus; GAS) infection and identifying patients at risk of developing RHD associated with GAS infection. The invention also provides methods and compositions for preventing and treating RHD associated with GAS infection.
    Type: Application
    Filed: October 20, 2010
    Publication date: November 1, 2012
    Inventors: Immaculada Margarit Y Ros, Reguzzi Valerio, Sohail Ahmed, Guido Grandi, Erika Bartolini
  • COMPOSITIONS COMPRISING YERSINIA PESTIS ANTIGENS
    Publication number: 20100183674
    Abstract: Disclosed are several Y. pestis antigens that are particularly suitable for immunisation purposes, particularly when used in combinations.
    Type: Application
    Filed: September 4, 2008
    Publication date: July 22, 2010
    Inventors: Renata Maria Grifantini, Guido Grandi, Maria Scarselli, Erika Bartolini, Elisabetta Frigimelica